European Journal of Chemistry

Development and validation of spectrophotometric methods for simultaneous determination of sitagliptin and simvastatin in binary mixture



Main Article Content

Sherif Abdel-Naby Abdel-Gawad
Zeinab Abdelaziz Elsherif

Abstract

Simple, selective and precise spectrophotometric methods were adopted for simultaneous determination of sitagliptin (SIT) and simvastatin (SIM) in new co-formulated pharmaceutical dosage form. In the first method, SIT was determined by measuring its zero order absorbance at 266.4 nm in the range of 40-360 µg/mL in the presence of up to 70% of SIM. While, the two cited drugs were determined simultaneously using third derivative method by measuring the sum of peak amplitudes (peak & valley) at 275.3-280.3 nm and 240.5-244.7 nm in the ranges of 40-360 µg/mL and 2-18 µg/mL for SIT and SIM, respectively. In the second method, the first derivative of ratio spectra method was applied by measuring the peak height at 255.9 and 275.2 nm using 18 µg/mL SIM as devisor over a concentration range of 40-360 µg/mL of SIT and at 228.3, 240.5 and 248 nm using 100 µg/mL of SIT as divisor over a concentration range 2-18 µg/mL SIM. In the third method the ratio subtraction spectrophotometric method was used, where SIM can be determined by dividing the spectra of the mixtures by the spectrum of SIT (40 µg/mL) followed by subtracting the constant absorbance value of the plateau, then finally multiply the produced spectrum by the spectrum of the devisor. Laboratory prepared mixtures were successfully tried for the three compositions of tablets (10, 20 and 40 mg of SIM) with 100 mg of SIT. The developed methods were validated as per International Conference of Harmonization guidelines.

3_4_447_454_800


icon graph This Abstract was viewed 2145 times | icon graph Article PDF downloaded 683 times

How to Cite
(1)
Abdel-Gawad, S. A.-N.; Elsherif, Z. A. Development and Validation of Spectrophotometric Methods for Simultaneous Determination of Sitagliptin and Simvastatin in Binary Mixture. Eur. J. Chem. 2012, 3, 447-454.

Article Details

Share
Crossref - Scopus - Google - European PMC
References

[1]. URL (10.24.2012): http://en.wikipedia.org/wiki/Sitagliptin.svs

[2]. URL (10.24.2012): http://www.drugbank.ca/drugs/DB01261

[3]. The United States Pharmacopeia USP 28, National Formulary, Press: The United States Pharmacopeial Convention, Inc., Rockville, pp. 1770-1772, 2006.

[4]. URL (10.24.2012): http://www.drugbank.ca/drugs/DB00641

[5]. URL (10.24.2012): http://www.medicalnewstoday.com/articles/235682.php

[6]. Bala, S. C.; Prameela, R. A. Ecl. Quim. Sao Paulo 2010, 35, 45-53.

[7]. El-Bagary, R. I.; Elkady, E. F.; Ayoub, B. M. Int. J. Biomed. Sci. 2011, 7, 55-61.

[8]. Xiang-Fei, J.; De-Wei, S.; Ye, C.; Xin-Gang, L.; Xiao-Meng, W.; Tian-Yan, Z.; Wei, L. J. Chin. Pharm. Sci. 2010, 20, 63-69.

[9]. Shyamala, M.; Mohideen, S.; Satyanarayana, T.; Suresh, K. P. N. R.; Swetha, K. Am. J. Pharm. Tech. Res. 2011, 1, 93-101.

[10]. El-Bagary, R. I.; Elkady, E. F.; Ayoub, B. M. Talanta 2011, 85, 673-680.
http://dx.doi.org/10.1016/j.talanta.2011.04.051
PMid:21645757

[11]. Nirogi, R.; Kandikere, V.; Mudigonda, K.; Komarneni, P.; Aleti, R.; Boggavarapu, R. Biomed. Chromatogr. 2008, 22, 214-222.
http://dx.doi.org/10.1002/bmc.926
PMid:17939170

[12]. Zeng, W.; Musson, D. G.; Fisher, A. L.; Chen, L.; Schwartz, M. S.; Woolf, E. J.; Wang, A. Q. J. Pharm. Biomed. Anal. 2008, 46, 534-542.
http://dx.doi.org/10.1016/j.jpba.2007.11.003
PMid:18096349

[13]. El-Bagary, R. I.; Elkady, E. F.; Ayoub, B. M. Talanta 2011, 85, 673-680.
http://dx.doi.org/10.1016/j.talanta.2011.04.051
PMid:21645757

[14]. El-Bagary, R. I.; Elkady, E. F.; Ayoub, B. M. Inter. J. Biomed. Sci. 2011, 7, 62-69.

[15]. Vineet, S.; Radhika, B.; Rahul, B. Rasayan, J. J. Chem. 2010, 3, 507-513.

[16]. Lei, W.; Mandana, A. J. Pharm. Biomed. Anal. 1999, 21, 1243-1248.

[17]. Arayne, M. S.; Sultana, N.; Hussain, F.; Ali, S. A. J. Anal. Chem. 2007, 62, 536-541.
http://dx.doi.org/10.1134/S106193480706007X

[18]. Anantha, K. D.; Sujan, D. P.; Vijayasree, V.; Seshagiri, J. V. R. E-J. Chem. 2009, 6, 541-544.

[19]. Hefnawy, M.; Al-Omar, M.; Julkhuf, S. J. Pharm. Biomed. Anal. 2009, 50, 527-534.
http://dx.doi.org/10.1016/j.jpba.2009.05.002
PMid:19487095

[20]. Ali, H.; Nazzal, S. J. Pharm. Biomed. Anal. 2009, 49, 950-956.
http://dx.doi.org/10.1016/j.jpba.2009.02.009
PMid:19286339

[21]. Nilesh, J.; Ruchi, J.; Hemant, S.; Deepak, K. J. Asian J. Res. Chem. 2008, 1, 29-31.

[22]. Nagaraju, P.; Vishnu, V. Z. J. Glob. Pharm. Technol. 2010, 2, 113-117.

[23]. Naotaka, U.; Kazuhide, I.; Shunsuke, H. J. Chromatogr. B. 1997, 694, 211-217.
http://dx.doi.org/10.1016/S0378-4347(97)00091-1

[24]. Carlucci, G.; Mazzeo, P.; Biordi, L.; Bologna, M. J. Pharm. Biomed. Anal. 1992, 10, 693-697.
http://dx.doi.org/10.1016/0731-7085(92)80098-8

[25]. Zhab, J. J.; Xie, I. H.; Yang, A. Y.; Roadcap, B. A.; Rogers, J. D. J. Mass Spectrom. 2000, 35, 1133-1143.
http://dx.doi.org/10.1002/1096-9888(200009)35:9<1133::AID-JMS42>3.0.CO;2-X

[26]. Jemal, M.; Ouyang, Z.; Powell, M. L. J. Pharm. Biomed. Anal. 2000, 23, 323-340.
http://dx.doi.org/10.1016/S0731-7085(00)00309-5

[27]. Wang, D.; Qin, F.; Chen, L.; Hao, Y.; Zhang, Y.; Li, F. Se Pu 2008, 26(3), 327-330.
PMid:18724669

[28]. Zhang, J.; Rodila, R.; Gage, E.; Hautman, M.; Fan, L. M.; King, L. L.; Wu, H. Q.; El-Shourbagy, T. A. Anal. Chim. Acta 2010, 661, 167-172.
http://dx.doi.org/10.1016/j.aca.2009.12.023
PMid:20113731

[29]. Ankur, K.; Sheetal, S. Int. J. Pharm. 2012, 2, 609-612.

[30]. Ketema, G.; Sankar, D. G. Inventi. Rapid. Pharm. Ana. Qual. Assur. 2012, 4, 876-881.

[31]. Gebremriam, K.; Gowris, S. Inventi Rapid Pharm Anal. Qual. Assur. 2012, 6, 621-631.

[32]. Burugula, L.; Mullangi, R.; Pilli, N.R.; Makula, A.; Lodagala, D.S.; Kandhagatla, R. Biomed. Chromatogr. 2012, 5(2), 102-111.

[33]. Morelli, B. J. Pharm. Sci. 1988, 77, 615-621.
http://dx.doi.org/10.1002/jps.2600770713

[34]. Morelli, B. J. Pharm. Sci. 1988, 77, 1042-1045.
http://dx.doi.org/10.1002/jps.2600771211

[35]. Morelli, B. J. Pharm. Sci. 1995, 84, 34-37.
http://dx.doi.org/10.1002/jps.2600840109

[36]. Talsky, G.; Marying, L.; Kreuzer, H. Angew. Chem. Int. Ed. Engl. 1978, 17, 785-799.
http://dx.doi.org/10.1002/anie.197807853

[37]. Rojas, F. S. Ojeda, C. B. Pavon, J. M. C. Talanta 1988, 45, 753-671.
http://dx.doi.org/10.1016/0039-9140(88)80179-6

[38]. URL (10.24.2012): http://www.medicines.org.uk/emc/medicine/15657

[39]. Salinas, F.; Nevado, J. J. Mansilla, A. E. Talanta 1990, 37, 347-351.
http://dx.doi.org/10.1016/0039-9140(90)80065-N

[40]. El-Bardicy, M. G.; Lotfy, H. M.; El-Sayed, M. A.; El-Tarras, M. F. J. AOAC Int. 2008, 91, 299-310.

[41]. International Conference on Harmonization (ICH), Q2B: Validation of Analytical Procedures: Methodology, 62, US FDA Federal Register, 1997.

Supporting Agencies

TrendMD

Dimensions - Altmetric - scite_ - PlumX

Downloads and views

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...
License Terms

License Terms

by-nc

Copyright © 2024 by Authors. This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at https://www.eurjchem.com/index.php/eurjchem/terms and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License (http://creativecommons.org/licenses/by-nc/4.0). By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution, or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License (https://www.eurjchem.com/index.php/eurjchem/terms) are administered by Atlanta Publishing House LLC (European Journal of Chemistry).